Recent Posts
- Lawsuit Prompts U.S. State Department To Strengthen Protections Of HIV-Positive Contract Workers
- San Francisco Postpones Agency Cuts, Los Angeles AIDS Clearinghouse Closes
- Kennedy’s Contributions To HIV/AIDS, Gay Rights Policies Recalled
- Routine Circumcision Does Not Protect Against HIV For Men Who Have Sex With Men, CDC Study Finds
- NBA Legend Dikembe Mutombo, UNICEF Executive Director Ann M. Veneman And BD Commemorate Opening Of New Center To Improve HIV/AIDS Treatment In The DRC
Random Posts
- Delaware HIV/AIDS Organization Forced To Close After 28 Years
- Potential For Creating Less Toxic Anti-HIV Drugs Following Discovery Of Enzyme Structure
- University Of Minnesota Research Finds Teens Who Believe They'll Die Young Are More Likely To Engage In Risky Behavior
- Los Angeles County's Commission On HIV Reconsiders Plan To Cut Nutrition Programs
- Global Fund Director Says G20 Can Become Donor Nations
- HIV Status Not Grounds For Denying People Professional Licenses, Federal Officials Say
- Montgomery County, Ala., Has Highest HIV/AIDS Rate In State
- Study Examines Gender Differences In Immune System's Response To HIV
- Global AIDS Coordinator Addresses Obama's Global HIV/AIDS Policy Agenda
- Report Looks At HIV Prevalence Among Chicago Gay Men
Prescription AIDS Drugs
Contact Us
Yale Physicians Receive $4.1 Million Grant To Study New Treatment For Alcohol-Dependent HIV-Positive Inmates Transitioning Back Into Society
November 05th, 2009
Two Yale School of Medicine physicians have been awarded a $4.1 million research grant from the National Institutes of Health (NIH) to study a new pharmacological treatment for newly released HIV-positive inmates with alcohol dependence who are transitioning back into the community.
The U.S. prison population is disproportionately impacted by HIV and by alcohol and drug abuse. A majority of HIV-positive inmates also have substance abuse disorders. Though many are treated successfully for both HIV and substance abuse while incarcerated, they face enormous challenges when released.
“Released HIV-positive inmates who relapse to alcohol and drug use are less likely to adhere to HIV treatment, including antiretroviral drugs, and more likely to engage in high-risk behavior,” according to Frederick L. Altice, M.D., professor at Yale School of Medicine, director of clinical and community research at the Yale AIDS Program and one of the two principal investigators.
The prestigious NIH grant is the first of its stature for Sandra Springer, M.D., assistant professor of medicine and co-principal investigator - a junior investigator whose career has already benefited from a career development award from the NIH. In the clinical trial led by Springer and Altice, 125 HIV-positive prisoners with alcohol dependence who are transitioning back into society will receive subcutaneous (depot) injections of naltrexone. Though the medication has been previously shown to benefit those with alcohol dependence, HIV-infected individuals were never previously included in clinical trials.
All subjects in the trial, whether getting naltrexone or the placebo, will receive comprehensive case-management services and 24 weeks of counseling. “This is the first time that depot naltrexone will be formally tested in HIV-infected patients,” says Springer. She adds, “We hope to learn whether a medication known to benefit those with alcohol problems will also help assist with HIV treatment and prevent a relapse to high-risk behaviors. Our study could confirm that treating one disease, alcohol dependence, can actually fight two life-threatening conditions.”
Source
Yale University
View drug information on Naltrexone Hydrochloride Tablets.
Related posts:
- Video Game To Help Urban Teens Avoid HIV Infection Focus Of Nearly $4 Million Grant To Yale Creating a video game to help teens avoid sex, drugs...
- Yale And University Of Malaya Join Forces To Battle HIV In Prisons In the hope of stemming one of the biggest...
- Program Once Reserved For Alabama Inmates With HIV/AIDS Expanded To All Inmates Patient / Public: Health Professional: Article Opinions: ...
- More Than Four Million HIV-positive People Now Receiving Life-saving Treatment More than 4 million people in low- and middle-income countries...
- Outstanding Minority Physicians Receive Awards Dedicated To HIV Medicine Two promising young physicians have been awarded this year’s Minority...
Related posts brought to you by Yet Another Related Posts Plugin.
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.